INDUSTRY Competitiveness

Verheugen in bid to boost Europe's pharmaceuticals

By Jennifer Rankin - 16.10.2008 / 00:00 CET

Commission to publish review of drug industry; EU pharma to compete with US and Asian firms.

Please log in to read this article:

Don't have a login yet?

Discover your benefits and register for free now! It only takes a minute.

Subscribe to European Voice for €15 per month

Almunia outlines Google competition concerns

Commissioner highlights four areas of concern and calls for a 'quick resolution'.

GÜNTER VERHEUGEN Wants more competitive pharma. EC

Fact file

The pharmaceutical package

õ Revised directive and regulation on pharmacovigilance (medicine safety and monitoring): to protect public health and improve the working of the internal market.
õ Revised regulation on information to patients: to set harmonised rules on what information drug companies can give to patients in the internet age.
õ Directive on counterfeit medicines: to improve traceability of products and crack down on counterfeiting.
õ Communication on the future of the single market in pharma-ceuticals: to review developments since 2004 and assess future challenges.